Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from ...
But Biogen isn’t resting on the success of Spinraza. In January 2022, the big biotech exercised an option from Ionis for an exclusive global license for another antisense oligonucleotide, BIIB115, ...
Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket ...
During the summer months, an average of one child a day goes to the emergency for a drowning or near... During the summer months, an average of one child a day goes to the emergency for a drowning or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback